{
    "version": "1.0",
    "type": "rich",
    "width": "",
    "height": "",
    "title": "Cabometyx og Opdivo-kombo gir dypere respons og lengre overlevelse for pasienter med avansert nyrecellekreft",
    "url": "https://www.healthtalk.no/asco-2022-legemidler-og-biotek/cabometyx-og-opdivo-kombo-gir-dypere-respons-og-lengre-overlevelse-for-pasienter-med-avansert-nyrecellekreft/100704",
    "author_name": "healthtalk",
    "author_url": "https://www.healthtalk.no",
    "provider_name": "Labrador",
    "provider_url": "http://www.labradorcms.com/",
    "html": "<div class=\"labrador-cms-embed\" data-lab-style=\" dac-embed-full\" data-lab-content=\"full\" data-lab-id=\"100704\" data-lab-site=\"www.healthtalk.no\"><script async defer src=\"https://www.healthtalk.no/embed.js?v=335\"></script></div>"
}